Company Filing History:
1 out of 1 
1 out of 19 Years Active: 2019
Title: The Innovations of Chi-Sheng Cheng
Introduction
Chi-Sheng Cheng is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of medical research, particularly in the area of cancer detection. His work focuses on the development of biomarkers that can aid in the early diagnosis of diseases.
Latest Patents
Chi-Sheng Cheng holds a patent for a peptide, antibody thereof, and method of assessing the risk of oral cancer by using peptide. The patent discloses a THLW peptide, with an amino acid sequence represented by SEQ ID No. 1. This THLW peptide serves as a biomarker for diseases such as oral cancer and cervical cancer, which are related to the infection of human papillomavirus (HPV). The THLW peptide can be utilized as an antigen or in the preparation of an anti-THLW peptide antibody to detect the risk of developing cancer in sample providers.
Career Highlights
Throughout his career, Chi-Sheng Cheng has been associated with prominent institutions such as Tunghai University and Taichung Veterans General Hospital. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Chi-Sheng Cheng has collaborated with notable colleagues, including Feng-Di Lung and Ye-song Gu. These partnerships have enhanced his research efforts and broadened the impact of his innovations.
Conclusion
Chi-Sheng Cheng's contributions to cancer research through his innovative peptide patent highlight the importance of early detection in medical science. His work continues to pave the way for advancements in cancer diagnostics.